Back to results
US 2022/0380477 A1Published application
Pharmaceutical composition comprising prion protein-specific antibody
AssigneeStem Bio Co., Ltd.
InventorSang Hun LEE
Life of this patent
Estimating the term…
Abstract
Proposed are a pharmaceutical composition for cancer treatment, comprising a prion protein-specific antibody, and a pharmaceutical composition for cancer treatment, comprising a complex of a target that binds to a prion protein antigenic determinant, and one or more selected from the group consisting of an anticancer drug, a chemotherapeutic agent, a toxin, a radioisotope, and a cytotoxic enzyme.
Claims4
A pharmaceutical composition for cancer treatment comprising a prion protein-specific antibody.
A pharmaceutical composition for cancer treatment, comprising a complex of a target that binds to a prion protein antigenic determinant;
- and one or more selected from the group consisting of an anticancer drug, a chemotherapeutic agent, a toxin, a radioisotope, and a cytotoxic enzyme.
Dependencies are inferred from the claim text.